GSK GlaxoSmithKline PLC ADR

USD 33.70 +0.35 ( +1.05)%
Icon

GlaxoSmithKline PLC ADR (GSK) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - General | NYE
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 33.70

+0.35 (+1.05)%

N/A

7.03M

USD 46.50(+37.98%)

USD 44.00 (+30.56%)

Icon

GSK

GlaxoSmithKline PLC ADR (USD)
COMMON STOCK | NYE
USD 33.70
+0.35 ( +1.05)%
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

N/A

USD 44.00 (+30.56%)

USD 33.70

GlaxoSmithKline PLC ADR (GSK) Stock Forecast

USD 46.50
(+37.98%)

Based on the GlaxoSmithKline PLC ADR stock forecast from 2 analysts, the average analyst target price for GlaxoSmithKline PLC ADR is USD 46.50 over the next 12 months. GlaxoSmithKline PLC ADR’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of GlaxoSmithKline PLC ADR is Slightly Bearish, which is based on 2 positive signals and 3 negative signals. At the last closing, GlaxoSmithKline PLC ADR’s stock price was USD 33.70. GlaxoSmithKline PLC ADR’s stock price has changed by -2.01% over the past week, -11.69% over the past month and -4.26% over the last year.

No recent analyst target price found for GlaxoSmithKline PLC ADR
No recent average analyst rating found for GlaxoSmithKline PLC ADR

Company Overview GlaxoSmithKline PLC ADR

N/A

N/A

N/A

N/A

USD

USA

Adjusted Closing Price for GlaxoSmithKline PLC ADR (GSK)

Loading...

Unadjusted Closing Price for GlaxoSmithKline PLC ADR (GSK)

Loading...

Share Trading Volume for GlaxoSmithKline PLC ADR Shares

Loading...

Compare Performance of GlaxoSmithKline PLC ADR Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for GSK

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To GlaxoSmithKline PLC ADR (Sector: Drug Manufacturers - General )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LLY
Eli Lilly and Company -3.49 (-0.46%) USD737.03B 86.94 63.35

Frequently Asked Questions About GlaxoSmithKline PLC ADR (GSK) Stock

Based on ratings from 2 analysts GlaxoSmithKline PLC ADR's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and 2 hold ratings.

Unfortunately we do not have enough data on GSK's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for GSK is USD 46.50 over the next 12 months. The maximum analyst target price is USD 53 while the minimum anlayst target price is USD 39.5.

Unfortunately we do not have enough data on GSK's stock to indicate if its overvalued.

The last closing price of GSK's stock was USD 33.70.

Unfortunately we do not currently have any market capitalization data for GSK's stock.

Based on targets from 2 analysts, the average taret price for GSK is projected at USD 46.50 over the next 12 months. This means that GSK's stock price may go up by +37.98% over the next 12 months.

We can't find any ETFs which contains GlaxoSmithKline PLC ADR's stock.

Sorry, we do not have any data on the number of employees for GlaxoSmithKline PLC ADR.

Sorry we do not have any infomation available on GlaxoSmithKline PLC ADR's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About GlaxoSmithKline PLC ADR (GSK) Stock

Based on ratings from 2 analysts GlaxoSmithKline PLC ADR's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and 2 hold ratings.

Unfortunately we do not have enough data on GSK's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for GSK is USD 46.50 over the next 12 months. The maximum analyst target price is USD 53 while the minimum anlayst target price is USD 39.5.

Unfortunately we do not have enough data on GSK's stock to indicate if its overvalued.

The last closing price of GSK's stock was USD 33.70.

Unfortunately we do not currently have any market capitalization data for GSK's stock.

Based on targets from 2 analysts, the average taret price for GSK is projected at USD 46.50 over the next 12 months. This means that GSK's stock price may go up by +37.98% over the next 12 months.

We can't find any ETFs which contains GlaxoSmithKline PLC ADR's stock.

Sorry, we do not have any data on the number of employees for GlaxoSmithKline PLC ADR.

Sorry we do not have any infomation available on GlaxoSmithKline PLC ADR's address.
Loading...